Singhe Hospitals Income Statement

Financials in millions LKR. Fiscal year is April - March.

Millions LKR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022	Mar '21 Mar 31, 2021
Revenue	1,730	1,507	1,272	1,072	1,002	700.34
Revenue Growth (YoY)	26.73%	18.42%	18.72%	6.99%	43.03%	4.27%
Cost of Revenue	592.29	521.15	507.42	461.08	452.89	269.16
Gross Profit	1,138	985.52	764.89	610.62	548.81	431.18
Selling, General & Admin	866.09	802.8	676.82	531.61	499.46	398.75
Other Operating Expenses	20.78	-1.12	-0.33	-0.67	-0.67	-0.15
Operating Expenses	886.87	801.68	676.49	530.94	498.79	398.6
Operating Income	251.01	183.84	88.4	79.68	50.02	32.58
Interest Expense	-23.09	-30.38	-55.14	-61.57	-33.9	-25.92
Interest & Investment Income	2.7	2.7	1.5	1.11	0.01	0.02
Other Non Operating Income (Expenses)	-7.95	-9.19	-2.27	-3.28	-1.98	-0.88
EBT Excluding Unusual Items	222.67	146.97	32.49	15.94	14.14	5.8
Gain (Loss) on Sale of Investments	-0	-0	-0	0.01	0	0.01
Pretax Income	222.66	146.97	32.49	15.95	14.14	5.8
Income Tax Expense	34.36	30.79	7.86	28.67	-2.27	3.5
Net Income	188.31	116.18	24.63	-12.73	16.41	2.3
Net Income to Common	188.31	116.18	24.63	-12.73	16.41	2.3
Net Income Growth	115.87%	371.73%	-	-	613.87%	-
Shares Outstanding (Basic)	445	431	431	431	431	431
Shares Outstanding (Diluted)	445	431	431	431	431	431
Shares Change (YoY)	4.93%	-	-	-	-	-
EPS (Basic)	0.42	0.27	0.06	-0.03	0.04	0.01
EPS (Diluted)	0.42	0.27	0.06	-0.03	0.04	0.01
EPS Growth	105.72%	371.74%	-	-	613.96%	-
Free Cash Flow	107.31	161.44	75.16	75.13	39.32	1.44
Free Cash Flow Per Share	0.24	0.37	0.17	0.17	0.09	0.00
Gross Margin	65.77%	65.41%	60.12%	56.98%	54.79%	61.57%
Operating Margin	14.51%	12.20%	6.95%	7.43%	4.99%	4.65%
Profit Margin	10.88%	7.71%	1.94%	-1.19%	1.64%	0.33%
Free Cash Flow Margin	6.20%	10.71%	5.91%	7.01%	3.92%	0.21%
EBITDA	312.46	240.79	135.99	134.69	127.17	101.97
EBITDA Margin	18.06%	15.98%	10.69%	12.57%	12.70%	14.56%
D&A For EBITDA	61.44	56.94	47.6	55.01	77.16	69.39
EBIT	251.01	183.84	88.4	79.68	50.02	32.58
EBIT Margin	14.51%	12.20%	6.95%	7.43%	4.99%	4.65%
Effective Tax Rate	15.43%	20.95%	24.19%	179.80%	-	60.37%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.